Cancer BiologyPLoS ONEPeer-reviewed
Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical Models
Yusuke Tomita, Gabrielle Link, Yi Ge…·Oren Josh Becher
This study evaluates combination therapy of CDK4/6 and MEK inhibitors in DMG models, finding survival benefits in GEM but not PDX models.
1 citation